Sibel Health Inc.
Chicago, IL Sibel Health Inc.
- UEI
- EHNPJMGCZRQ9
- CAGE
- 8AM57
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2017 N Mendell St Unit 2SE, Chicago, IL 60614, USA
- Website
- sibelhealth.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Arpa-h sbir phase II: advanced multimodal wearable edema monitoring platform | Interior Business Center | $3,497,930 | |
| Novel AI-enabled wearable sensor for scratch monitoring - project summary itch is a distressing and highly prevalent… | FDA Office of Acquisition and Grant Services | $499,998 | |
| DDT-COA-000167: digital sensor for monitoring swallow count and respiratory coordination in parkinson's disease patients… | FDA Office of Acquisition and Grant Services | $748,399 | |
| DHA sbir DPH II HD2-0101 | Medical Command | $1,096,731 | |
| Low burden wearable sensor system for diagnosing obstructive sleep apnea in older adults | National Heart Lung and Blood Institute | $224,672 |
About Sibel Health Inc.
Sibel Health Inc., a Chicago-based small business specializing in advanced wearable sensor technologies and AI-enabled medical devices for objective biomarker detection, operates as a prime recipient on federal research contracts and grants (63% of recent awards) and as a subrecipient on pediatric device-innovation grants. The company competes under Total Small Business set-asides on its prime contract work with the Department of Defense and the National Institutes of Health, with additional cooperation-agreement funding from the Food and Drug Administration.
Sibel Health's capability portfolio centers on multimodal wearable sensors combined with machine learning for quantifiable health monitoring in neurological, dermatological, and respiratory disease populations. The company's flagship platform, the ADAM (Acoustic Detection and Motion) device, detects scratching behavior as an objective biomarker for atopic dermatitis itch severity, monitors swallowing and respiratory coordination in Parkinson's disease patients with dysphagia, and detects frostbite risk through soft miniaturized wireless sensors. Recent prime contract work includes a $3.5 million firm fixed-price SBIR Phase II award from the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H) for development of an advanced multimodal wearable edema monitoring platform (ultimate completion March 1, 2028); a $1.1 million Total Small Business SBIR Phase II contract from the Army Medical Command for time-synchronized soft miniaturized wireless sensors for remote frostbite prevention (awarded September 2022, completion July 15, 2025); and a $500 thousand FDA Cooperative Agreement (CFDA 93.103) awarded September 24, 2025, for validation of the ADAM device in 30 pediatric and adult atopic dermatitis patients (completion June 30, 2027). A second FDA Cooperative Agreement from the Center for Drug Evaluation and Research, awarded September 1, 2024, funds clinical validation of the ADAM sensor for swallowing and respiratory monitoring in Parkinson's disease patients at Northwestern University.
Customer concentration is heavily skewed toward Department of Health and Human Services agencies. The National Institutes of Health, the FDA, the National Heart, Lung, and Blood Institute, and the Office of the Assistant Secretary for Preparedness and Response collectively account for 88% of recent awards; the NIH's $3.5 million ARPA-H contract and the Army Medical Command's $1.1 million SBIR Phase II together represent 100% of the disclosed combined potential value. Three awards (combined potential value $3.5 million) reach completion within the next twenty-four months, creating recompete exposure. Sibel Health operates as a subrecipient on pediatric device-innovation grant work under the Children's Research Institute, the prime grantee for two Alliance for Pediatric Device Innovation sub-awards (October and November 2024) and a BARDA Accelerator Network 2.0 Special Populations Hub sub-contract (September 2025).
Quick answers
What is Sibel Health Inc.'s UEI?
Sibel Health Inc.'s Unique Entity ID (UEI) in SAM.gov is EHNPJMGCZRQ9.
What is Sibel Health Inc.'s CAGE code?
Sibel Health Inc.'s CAGE code is 8AM57.
What is Sibel Health Inc.'s primary NAICS code?
Sibel Health Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Sibel Health Inc. located?
Sibel Health Inc.'s physical address in SAM.gov is 2017 N Mendell St Unit 2SE, Chicago, IL 60614, USA.
Is Sibel Health Inc. registered in SAM.gov?
Yes. Sibel Health Inc.'s SAM.gov registration is active through July 17, 2027.
What is Sibel Health Inc.'s most recent federal award?
Sibel Health Inc.'s most recent federal contract award is Arpa-h sbir phase II: advanced multimodal wearable edema monitoring platform (140D0426C0027), from Interior Business Center, on March 2, 2026.
On GovTribe
See Sibel Health Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors